BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28639914)

  • 1. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
    Wang Z; Wang X; Zhang D; Yu Y; Cai L; Zhang C
    Tumour Biol; 2017 Jun; 39(6):1010428317709990. PubMed ID: 28639914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.
    Eissa S; Matboli M; Essawy NO; Shehta M; Kotb YM
    Biomarkers; 2015; 20(3):212-7. PubMed ID: 26161701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis.
    Cui X; Jing X; Long C; Yi Q; Tian J; Zhu J
    Oncotarget; 2017 May; 8(21):35222-35233. PubMed ID: 28415640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Eissa S; Matboli M; Essawy NO; Kotb YM
    Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
    Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
    Tai CJ; Liao CF; Su TC; Shen KH; Chang CC; Lin SH; Yeh CM; Shen SC; Lee WR; Chiou JF; Lin CH; Chen YC; Shih HY; Yeh KT; Jiang MC
    Int J Biol Markers; 2012 Oct; 27(3):e280-4. PubMed ID: 22653741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
    Chen C; Shang A; Sun Z; Gao Y; Huang J; Ping Y; Chang W; Gu C; Sun J; Ji P; Yuan Y; Lu R; Li D
    J Immunol Res; 2022; 2022():9038808. PubMed ID: 35127956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary protein biomarker panel for the detection of recurrent bladder cancer.
    Rosser CJ; Chang M; Dai Y; Ross S; Mengual L; Alcaraz A; Goodison S
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1340-5. PubMed ID: 24714076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence.
    Vriesema JL; Atsma F; Kiemeney LA; Peelen WP; Witjes JA; Schalken JA
    Urology; 2001 Sep; 58(3):367-71. PubMed ID: 11549482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
    Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
    Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis.
    Yang X; Huang H; Zeng Z; Zhao L; Hu P; He D; Tang X; Zeng Z
    Clin Biochem; 2013 Oct; 46(15):1377-82. PubMed ID: 23735602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
    Tan WS; Tan WP; Tan MY; Khetrapal P; Dong L; deWinter P; Feber A; Kelly JD
    Cancer Treat Rev; 2018 Sep; 69():39-52. PubMed ID: 29902678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
    Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
    Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
    Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
    Mi Y; Zhao Y; Shi F; Zhang M; Wang C; Liu X
    Asia Pac J Clin Oncol; 2019 Apr; 15(2):e11-e19. PubMed ID: 29931834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study.
    Kavalieris L; O'Sullivan P; Frampton C; Guilford P; Darling D; Jacobson E; Suttie J; Raman JD; Shariat SF; Lotan Y
    J Urol; 2017 Jun; 197(6):1419-1426. PubMed ID: 27986532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sathyapalan T; Sahebkar A
    Biomed Res Int; 2021; 2021():5557309. PubMed ID: 33997007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.